Build a leaner path to your next clinical milestone
Fractional clinical development, operations and AI strategy for emerging biotech companies
Fractional clinical development, operations and AI strategy for emerging biotech companies
We help emerging biotech leaders make practical decisions about clinical operations, CROs and vendors, sponsor oversight, technology, and responsible uses of AI—without adding unnecessary infrastructure, cost, or complexity.
Moving an asset toward or into the clinic requires decisions about what to build, what to outsource, which partners and systems are necessary, and how to maintain sponsor oversight while preserving capital. As your fractional advisor, I work directly with leadership and clinical teams to clarify priorities, identify risks, and create a practical path forward.
If your organization is approaching a clinical milestone or facing an important operating decision, let's discuss where focused fractional guidance could help.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.